Drug intelligence / Profile preview

1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide is a synthetic small molecule with the chemical formula C9H16N2O7. It has been studied primarily as an experimental ligand and inhibitor of glycogen phosphorylase, particularly the muscle isoform (PYGM). Glycogen phosphorylase is a key enzyme in glycogen catabolism, catalyzing the rate-limiting step in the breakdown of glycogen to glucose-1-phosphate, thus playing a central role in cellular and organismal glucose homeostasis. By binding to this enzyme, 1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide can modulate its activity, making it of interest for research into metabolic regulation and potential therapeutic targeting of disorders involving glycogen metabolism[3][9][10]. There is no evidence that this compound has been developed or marketed as a pharmaceutical product.

Other names
CR6CR-6CR 6
02

Targets

PYGM (Glycogen phosphorylase, muscle form)

Beyond the preview

Go deeper on 1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call